Sanjay TrivediSep 3, 20175 min readIndia firms took 40% of new U.S. approvals for generics in 1HThe most recent earnings reports across the generic drug industry read like dispatches from the front lines of a price war, with their...
Sanjay TrivediFeb 26, 20171 min readAbbott to make India hub of global research & development for genericsAt a time when multinational drug companies are scaling down their research and development investments in India, citing lax patent rules...
